The city and state hope the development will revitalize the near west side and spur a new era of research in Indianapolis. Elanco, an animal health research company spun off from Eli Lilly and Co ...
With a market cap of $759.4 billion, Eli Lilly operates across diverse therapeutic areas, providing cutting-edge solutions in oncology, diabetes, immunology, and neuroscience. The Indianapolis ...
Eli Lilly and Co. announced Monday that it is buying Boston-based Scorpion Therapeutics and its targeted breast cancer treatment program in a deal worth up to $2.5 billion. The Indianapolis-based ...
Indianapolis-based Eli Lilly and Co. is projecting approval of its experimental weight-loss pill as soon as early 2026, CEO Dave Ricks said, one of several in a new generation of the popular drugs.
Conner Prairie is reimagining storytelling and community engagement surrounding the Lenape people and their traditions, ...
A two-car crash early Friday morning just west of downtown Indianapolis left a gaping hole in the side of a nearby house. The Indianapolis Fire Department says the crash happened just after 1:15 a ...
Eli Lilly's GLP-1 market dominance, supported by superior efficacy and strong manufacturing investments, positions it as a leader alongside Novo Nordisk, with forecasted revenue growth to $75B by ...
Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens ... Shares of the Indianapolis-based drugmaker were up 1.14% in after-market trading ...
Christmas has come early for Eli Lilly this year, courtesy of a fresh FDA approval for the Indianapolis drugmaker’s obesity star Zepbound. With the FDA’s green light on Friday, Lilly’s dual ...
Get the latest storm updates at this link. Indiana's first snowstorm of the year — predicted by the National Weather Service Indianapolis for days — is well underway in Indianapolis and across ...
Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly LLY and Novo Nordisk NVO stock. As the major players in the hyper-scale ...